CLINICAL_TRIALS
trial_result
· 2015-06-02
Clinical Trial Update: A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) [Phase 3]
Summary
Phase 3 trial of RO4917838 in schizophrenia has completed; the update notes the study status but does not provide results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED